Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Edelman

Showing results (991-1000 of 993) with videos related to

Pageof 100
Sort By:
You have reached the last page of results.This site can display upto 993 results.
Circulation|August 11, 2017
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)David E Kandzari, Pieter C Smits, Michael P Love, et al.
Frontiers in Cardiovascular Medicine|May 10, 2024
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndromeLeslie B Gordon, Sammy Basso, Justine Maestranzi, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Pageof 100

Showing results (991-1000 of 993) with videos related to

Sort By:
Pageof 100
You have reached the last page of results.This site can display upto 993 results.
Circulation|August 11, 2017
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)David E Kandzari, Pieter C Smits, Michael P Love, et al.
Frontiers in Cardiovascular Medicine|May 10, 2024
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndromeLeslie B Gordon, Sammy Basso, Justine Maestranzi, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Pageof 100